603669 灵康药业
已收盘 10-26 15:00:00
资讯
新帖
简况
灵康药业(603669)2026年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 10-25 06:03
灵康药业(603669)2026年三季报简析:营收净利润同比双双增长,盈利能力上升
灵康药业(603669)9月30日股东户数2.56万户,较上期减少6.17%
证券之星 · 10-24 17:08
灵康药业(603669)9月30日股东户数2.56万户,较上期减少6.17%
灵康药业(603669.SH)发布前三季度业绩,归母净利润3183万元,同比扭亏为盈
智通财经 · 10-23
灵康药业(603669.SH)发布前三季度业绩,归母净利润3183万元,同比扭亏为盈
灵康药业(603669)10月23日主力资金净买入2156.27万元
证券之星 · 10-23
灵康药业(603669)10月23日主力资金净买入2156.27万元
异动快报:灵康药业(603669)10月22日11点4分触及跌停板
证券之星 · 10-22
异动快报:灵康药业(603669)10月22日11点4分触及跌停板
灵康药业(603669)10月13日主力资金净买入3386.57万元
证券之星 · 10-13
灵康药业(603669)10月13日主力资金净买入3386.57万元
股市必读:灵康药业新发布《可转债转股结果暨股份变动公告》
证券之星 · 10-12
股市必读:灵康药业新发布《可转债转股结果暨股份变动公告》
灵康药业(603669)10月9日主力资金净买入1071.97万元
证券之星 · 10-09
灵康药业(603669)10月9日主力资金净买入1071.97万元
灵康药业(603669)10月8日主力资金净买入2388.54万元
证券之星 · 10-08
灵康药业(603669)10月8日主力资金净买入2388.54万元
股市必读:灵康药业新发布《关于全资子公司获得注射用硫酸艾沙康唑注册证书的公告》
证券之星 · 10-08
股市必读:灵康药业新发布《关于全资子公司获得注射用硫酸艾沙康唑注册证书的公告》
灵康药业(603669)9月30日主力资金净买入2018.40万元
证券之星 · 09-30
灵康药业(603669)9月30日主力资金净买入2018.40万元
灵康药业(603669.SH):注射用硫酸艾沙康唑获得药品注册证书
智通财经 · 09-29
灵康药业(603669.SH):注射用硫酸艾沙康唑获得药品注册证书
股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》
证券之星 · 09-14
股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》
每周股票复盘:灵康药业(603669)拟下修转股价获股东会审议
证券之星 · 09-13
每周股票复盘:灵康药业(603669)拟下修转股价获股东会审议
股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》
证券之星 · 09-11
股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》
每周股票复盘:灵康药业(603669)拟下修转股价格
证券之星 · 09-06
每周股票复盘:灵康药业(603669)拟下修转股价格
股市必读:灵康药业新发布《第五届董事会第十二次会议决议公告》
证券之星 · 09-01
股市必读:灵康药业新发布《第五届董事会第十二次会议决议公告》
灵康药业(603669)披露关于向下修正“灵康转债”转股价格的议案,8月31日股价下跌2.73%
证券之星 · 08-31
灵康药业(603669)披露关于向下修正“灵康转债”转股价格的议案,8月31日股价下跌2.73%
灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%
证券之星 · 08-17
灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%
灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-16
灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升
暂无数据
公司概况
公司名称:
灵康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-28
主营业务:
灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是肠外营养药、抗感染药、消化系统药、心脑血管药。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉、灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。
发行价格:
11.70
{"stockData":{"symbol":"603669","market":"SH","secType":"STK","nameCN":"灵康药业","latestPrice":7.03,"timestamp":1792998000000,"preClose":6.74,"halted":0,"volume":45885190,"delay":0,"changeRate":0.043,"floatShares":712000000,"shares":712000000,"eps":-0.1782,"marketStatus":"已收盘","change":0.29,"latestTime":"10-26 15:00:00","open":6.87,"high":7.32,"low":6.81,"amount":325000000,"amplitude":0.0757,"askPrice":7.04,"askSize":397,"bidPrice":7.03,"bidSize":339,"shortable":0,"etf":0,"ttmEps":-0.1782,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793064600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.74,"symbolType":"stock","openAndCloseTimeList":[[1792978200000,1792985400000],[1792990800000,1792998000000]],"highLimit":7.41,"lowLimit":6.07,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":712360379,"isCdr":false,"pbRate":8.46,"roa":"--","roe":"5.0%","epsLYR":-0.27,"committee":0.425361,"marketValue":5008000000,"turnoverRate":0.0644,"status":0,"floatMarketCap":5008000000},"requestUrl":"/m/hq/s/603669/tweets","defaultTab":"tweets","newsList":[{"id":"2678185679","title":"灵康药业(603669)2026年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2678185679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678185679?lang=zh_cn&edition=full","pubTime":"2026-10-25 06:03","pubTimestamp":1792879402,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期灵康药业发布2026年三季报。截至本报告期末,公司营业总收入3.6亿元,同比上升27.79%,归母净利润3182.66万元,同比上升192.24%。按单季度数据看,第三季度营业总收入1.03亿元,同比下降6.83%,第三季度归母净利润1071.39万元,同比上升770.67%。本报告期灵康药业盈利能力上升,毛利率同比增幅9.97%,净利率同比增幅172.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500000249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677044269","title":"灵康药业(603669)9月30日股东户数2.56万户,较上期减少6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677044269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677044269?lang=zh_cn&edition=full","pubTime":"2026-10-24 17:08","pubTimestamp":1792832884,"startTime":"0","endTime":"0","summary":"证券之星消息,近日灵康药业披露,截至2026年9月30日公司股东户数为2.56万户,较6月30日减少1681.0户,减幅为6.17%。在化学制药行业个股中,灵康药业股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年6月30日至2026年9月30日,灵康药业区间涨幅为11.64%,在此期间股东户数减少1681.0户,减幅为6.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400013950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940058","title":"灵康药业(603669.SH)发布前三季度业绩,归母净利润3183万元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940058?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:55","pubTimestamp":1792749351,"startTime":"0","endTime":"0","summary":"智通财经APP讯,灵康药业(603669.SH)披露2026年第三季度报告,前三季度公司实现营业收入3.6亿元,同比增长27.79%;归属于上市公司股东的净利润3183万元,同比扭亏为盈;扣非净利润2361万元,同比扭亏为盈;基本每股收益0.0441元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677946506","title":"灵康药业(603669)10月23日主力资金净买入2156.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677946506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677946506?lang=zh_cn&edition=full","pubTime":"2026-10-23 15:22","pubTimestamp":1792740176,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月23日收盘,灵康药业报收于6.74元,上涨4.82%,换手率6.72%,成交量47.9万手,成交额3.01亿元。10月23日的资金流向数据方面,主力资金净流入2156.27万元,占总成交额7.17%,游资资金净流入459.99万元,占总成交额1.53%,散户资金净流出2616.26万元,占总成交额8.7%。灵康药业主营业务:化药处方药的研发、生产和销售.。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300022892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677987806","title":"异动快报:灵康药业(603669)10月22日11点4分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2677987806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677987806?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:05","pubTimestamp":1792638334,"startTime":"0","endTime":"0","summary":"证券之星10月22日盘中消息,11点4分灵康药业(603669)触及跌停板。其所属行业化学制药目前下跌。领涨股为百利天恒。该股为民营医院,西藏概念,阿尔茨海默病概念热股。10月21日的资金流向数据方面,主力资金净流入1201.13万元,占总成交额3.81%,游资资金净流出2349.37万元,占总成交额7.46%,散户资金净流入1148.24万元,占总成交额3.64%。近5日资金流向一览见下表:灵康药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200014589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675339819","title":"灵康药业(603669)10月13日主力资金净买入3386.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675339819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675339819?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:22","pubTimestamp":1791876124,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,灵康药业报收于7.24元,上涨7.58%,换手率10.52%,成交量74.95万手,成交额5.38亿元。10月13日的资金流向数据方面,主力资金净流入3386.57万元,占总成交额6.3%,游资资金净流出1958.09万元,占总成交额3.64%,散户资金净流出1428.48万元,占总成交额2.66%。灵康药业主营业务:化药处方药的研发、生产和销售.。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300020028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","603669","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674284550","title":"股市必读:灵康药业新发布《可转债转股结果暨股份变动公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674284550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674284550?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:05","pubTimestamp":1791741915,"startTime":"0","endTime":"0","summary":"公司公告汇总可转债转股结果暨股份变动公告灵康药业集团股份有限公司发布可转债转股结果暨股份变动公告。2026年7月1日至9月30日,“灵康转债”转股金额为189,000元,因转股形成的股份数量为29,214股,占转股前总股本的0.0041%。截至2026年9月30日,累计67,400,000元可转债已转换为公司股票,累计转股数量7,836,272股,占可转债开始转股前总股本的1.0984%。期间公司总股本由712,331,165股增至712,360,379股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674788839","title":"灵康药业(603669)10月9日主力资金净买入1071.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674788839","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674788839?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:23","pubTimestamp":1791530584,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月9日收盘,灵康药业报收于6.96元,上涨4.82%,换手率6.55%,成交量46.66万手,成交额3.18亿元。10月9日的资金流向数据方面,主力资金净流入1071.97万元,占总成交额3.37%,游资资金净流入951.67万元,占总成交额2.99%,散户资金净流出2023.64万元,占总成交额6.35%。灵康药业主营业务:化药处方药的研发、生产和销售.。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033029","title":"灵康药业(603669)10月8日主力资金净买入2388.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673033029?lang=zh_cn&edition=full","pubTime":"2026-10-08 15:22","pubTimestamp":1791444159,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月8日收盘,灵康药业报收于6.64元,上涨4.9%,换手率7.17%,成交量51.1万手,成交额3.38亿元。10月8日的资金流向数据方面,主力资金净流入2388.54万元,占总成交额7.06%,游资资金净流入2050.16万元,占总成交额6.06%,散户资金净流出4438.7万元,占总成交额13.12%。灵康药业主营业务:化药处方药的研发、生产和销售.。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800014009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","603669","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673678014","title":"股市必读:灵康药业新发布《关于全资子公司获得注射用硫酸艾沙康唑注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673678014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673678014?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:00","pubTimestamp":1791392437,"startTime":"0","endTime":"0","summary":"公司公告汇总:全资子公司获注射用硫酸艾沙康唑《药品注册证书》,适用于治疗成人侵袭性曲霉病和侵袭性毛霉病,已投入研发费用732.10万元。公司公告汇总关于全资子公司获得注射用硫酸艾沙康唑注册证书的公告灵康药业全资子公司海南灵康制药有限公司收到国家药监局核准签发的注射用硫酸艾沙康唑《药品注册证书》,药品注册分类为化学药品4类,批准文号有效期至2031年9月21日。2025年该药品市场销售额为4.23亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671276252","title":"灵康药业(603669)9月30日主力资金净买入2018.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671276252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671276252?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:21","pubTimestamp":1790752919,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,灵康药业报收于6.33元,上涨5.32%,换手率5.04%,成交量35.87万手,成交额2.22亿元。9月30日的资金流向数据方面,主力资金净流入2018.4万元,占总成交额9.08%,游资资金净流入825.32万元,占总成交额3.71%,散户资金净流出2843.73万元,占总成交额12.79%。灵康药业主营业务:化药处方药的研发、生产和销售.。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000018850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","603669","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671029128","title":"灵康药业(603669.SH):注射用硫酸艾沙康唑获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2671029128","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671029128?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:41","pubTimestamp":1790667715,"startTime":"0","endTime":"0","summary":"智通财经APP讯,灵康药业(603669.SH)发布公告,近日,公司全资子公司海南灵康制药有限公司(以下简称“灵康制药”)收到国家药品监督管理局(以下简称 “国家药监局”)核准签发的注射用硫酸艾沙康唑《药品注册证书》。公司注射用硫酸艾沙康唑获得国家药监局的《药品注册证书》,标志着公司具备了在国内市场生产销售该药品的资格,进一步丰富了公司抗感染类药物的产品线,有助于提升公司产品的市场竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"灵康药业(603669.SH):注射用硫酸艾沙康唑获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0033","603669","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667389196","title":"股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667389196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667389196?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:25","pubTimestamp":1789327513,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,灵康药业报收于5.12元,下跌3.21%,换手率2.46%,成交量17.52万手,成交额8945.42万元。公司公告汇总:灵康药业将于9月16日召开2026年第二次临时股东大会,审议向下修正“灵康转债”转股价格的议案。董事会提议依据募集说明书相关条款向下修正转股价格,以支持公司长期发展、优化资本结构、维护投资者权益,并提请股东大会授权董事会确定修正后的转股价格、生效日期及相关事宜,办理全部手续。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","603669","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500507","title":"每周股票复盘:灵康药业(603669)拟下修转股价获股东会审议","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500507?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:21","pubTimestamp":1789240870,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,灵康药业报收于5.12元,较上周的5.22元下跌1.92%。本周,灵康药业9月10日盘中最高价报5.44元。灵康药业当前最新总市值36.47亿元,在化学制药板块市值排名114/149,在两市A股市值排名3878/5218。本周关注点公司公告汇总:灵康药业将于2026年9月16日召开临时股东会,审议下修“灵康转债”转股价格的议案。股东大会将授权董事会确定修正后的转股价格、生效日期及相关手续办理事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518568","title":"股市必读:灵康药业新发布《2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666518568?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:51","pubTimestamp":1789066270,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,灵康药业报收于5.29元,上涨0.0%,换手率2.33%,成交量16.63万手,成交额8851.18万元。公司公告汇总2026年第二次临时股东会会议资料灵康药业集团股份有限公司将于2026年9月16日召开第二次临时股东会,审议关于向下修正“灵康转债”转股价格的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365097","title":"每周股票复盘:灵康药业(603669)拟下修转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365097","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365097?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:41","pubTimestamp":1788633671,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,灵康药业报收于5.22元,较上周的5.49元下跌4.92%。本周,灵康药业9月3日盘中最高价报5.58元。公司公告汇总第五届董事会第十二次会议决议公告灵康药业集团股份有限公司于2026年8月31日召开第五届董事会第十二次会议,审议通过《关于向下修正“灵康转债”转股价格的议案》,旨在优化资本结构并维护投资者权益。董事会同意向下修正转股价格,并提请股东大会授权董事会办理相关事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664500091","title":"股市必读:灵康药业新发布《第五届董事会第十二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664500091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664500091?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:42","pubTimestamp":1788201732,"startTime":"0","endTime":"0","summary":"公司公告汇总:董事会审议通过向下修正“灵康转债”转股价格的议案,触发条件为股价连续三十个交易日中至少十五日收盘价低于当期转股价的85%。公司公告汇总第五届董事会第十二次会议决议公告灵康药业集团股份有限公司于2026年8月31日召开第五届董事会第十二次会议,审议通过《关于向下修正“灵康转债”转股价格的议案》,拟优化资本结构并维护投资者权益;该议案尚需提交公司2026年第二次临时股东大会审议,并同意召开该股东大会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663207243","title":"灵康药业(603669)披露关于向下修正“灵康转债”转股价格的议案,8月31日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663207243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663207243?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:50","pubTimestamp":1788173442,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,灵康药业报收于5.34元,较前一交易日下跌2.73%,最新总市值为38.04亿元。该股当日开盘5.4元,最高5.45元,最低5.29元,成交额达9680.02万元,换手率为2.53%。近日,灵康药业集团股份有限公司披露《关于召开2026年第二次临时股东会的通知》,公告显示公司将于2026年9月16日召开2026年第二次临时股东会,会议审议《关于向下修正“灵康转债”转股价格的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489923","title":"灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489923","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660489923?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:54","pubTimestamp":1786960484,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘,灵康药业报收于6.36元,较前一交易日上涨1.11%,最新总市值为45.3亿元。该股当日开盘6.3元,最高6.45元,最低6.15元,成交额达1.48亿元,换手率为3.29%。近日,灵康药业披露《2026年半年度报告》。公告显示,公司总资产为1,124,036,756.48元,较上年度末增长1.56%;归属于上市公司股东的净资产为641,401,611.76元,较上年度末增长3.40%。公司半年度不进行利润分配或资本公积转增股本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700024132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","603669","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179304","title":"灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659179304?lang=zh_cn&edition=full","pubTime":"2026-08-16 06:02","pubTimestamp":1786831346,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期灵康药业发布2026年中报。截至本报告期末,公司营业总收入2.57亿元,同比上升50.03%,归母净利润2111.27万元,同比上升159.08%。按单季度数据看,第二季度营业总收入1.71亿元,同比上升40.69%,第二季度归母净利润1815.68万元,同比上升206.1%。本报告期灵康药业盈利能力上升,毛利率同比增幅131.06%,净利率同比增幅139.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600001252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793055614265,"stockEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.1915},{"period":"3month","weight":0.3519},{"period":"6month","weight":0.5451},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.5417}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":-0.0491},{"period":"3month","weight":-0.0304},{"period":"6month","weight":-0.0998},{"period":"1year","weight":-0.064},{"period":"ytd","weight":-0.0684}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"灵康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25582人(较上一季度减少6.17%)","perCapita":"27846股","listingDate":"2015-05-28","address":"西藏自治区山南市乃东区国道349号(结巴乡段)20号","registeredCapital":"71236万元","survey":" 灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是肠外营养药、抗感染药、消化系统药、心脑血管药。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉、灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。","listedPrice":11.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"灵康药业,603669,灵康药业股票,灵康药业股票老虎,灵康药业股票老虎国际,灵康药业行情,灵康药业股票行情,灵康药业股价,灵康药业股市,灵康药业股票价格,灵康药业股票交易,灵康药业股票购买,灵康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}